CD44 and graft versus host disease: Disease severity and recruitment of lymphocytes in animal models of acute asthma, arthritis, and graft-versus-host disease are reduced by antibody blockade of CD44 or CD44 deficiency, as well as by enzymatic depletion of endothelial HA (6–8).